3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
56
Lung Neoplasms
27
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Neoplasms
5
Neoplasm Metastasis
4
Colorectal Neoplasms
4
Colonic Neoplasms
3
Advanced Solid Tumors
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Non-squamous Non-small Cell Lung Cancer
2
Mesothelioma
2
Meningeal Carcinomatosis
2
Melanoma
2
Lung Diseases
2
Esophageal Neoplasms
2
Carcinoma
2
Adenocarcinoma of Lung
2
Uterine Cervical Neoplasms
1
Thoracic Neoplasms
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Pathologic Processes
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Interventions
Cyclophosphamide
3
Vincristine
2
Rituximab
2
Prednisone
2
Etoposide
2
Doxorubicin
2
pembrolizumab
1
liposomal doxorubicin
1
etoposide phosphate
1
Zidovudine
1
Valganciclovir
1
Sirolimus
1
Nivolumab
1
Interferon-alpha
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Bortezomib
1
Biological Assay
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoproliferative Disorders
×
Pemetrexed
×
30 days
×
Clear all
No trials found.